Nanotoxicity assessment: all small talk?
Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
In vitro assessments of nanomaterial toxicity
Effects of nanomaterial physicochemical properties on in vivo toxicity
Magnetic nanoparticles for theragnostics
Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity